HomeInsightsStock Comparison

Par Drugs Chemicals Ltd vs Unjha Formulations Ltd Stock Comparison

Par Drugs Chemicals Ltd vs Unjha Formulations Ltd Stock Comparison

Last Updated on: May 14, 2025

Key Highlights

  • The Latest Trading Price of Par Drugs & Chemicals Ltd is ₹ 101 as of 14 May 10:57.
  • The P/E Ratio of Par Drugs & Chemicals Ltd changed from 4.1 on March 2020 to 18.3 on March 2024 . This represents a CAGR of 34.88% over 5 yearsThe P/E Ratio of Unjha Formulations Ltd changed from 8.3 on March 2020 to 30.5 on March 2024 . This represents a CAGR of 29.73% over 5 years.
  • The Market Cap of Par Drugs & Chemicals Ltd changed from ₹ 19.38 crore on March 2020 to ₹ 265.1 crore on March 2024 . This represents a CAGR of 68.74% over 5 yearsThe Market Cap of Unjha Formulations Ltd changed from ₹ 2.58 crore on March 2020 to ₹ 8.47 crore on March 2024 . This represents a CAGR of 26.84% over 5 years.
  • The revenue of Par Drugs & Chemicals Ltd for the Mar '25 is ₹ 23.12 crore as compare to the Dec '24 revenue of ₹ 21.65 crore. This represent the growth of 6.79% The revenue of Unjha Formulations Ltd for the Mar '25 is ₹ 0 crore as compare to the Dec '24 revenue of ₹ 3.77 crore. This represent the decline of -100%.
  • The ebitda of Par Drugs & Chemicals Ltd for the Mar '25 is ₹ 3.22 crore as compare to the Dec '24 ebitda of ₹ 1.7 crore. This represent the growth of 89.41% The ebitda of Unjha Formulations Ltd for the Mar '25 is ₹ 0 crore as compare to the Dec '24 ebitda of ₹ 0.25 crore. This represent the decline of -100%.
  • The net profit of Par Drugs & Chemicals Ltd changed from ₹ 2.47 crore to ₹ 1.65 crore over 8 quarters. This represents a CAGR of -18.27% The net profit of Unjha Formulations Ltd changed from ₹ 0.18 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of -100.00% .
  • The Dividend Payout of Par Drugs & Chemicals Ltd changed from 33.42 % on March 2020 to 0 % on March 2024 . This represents a CAGR of -100.00% over 5 yearsThe Dividend Payout of Unjha Formulations Ltd changed from 0 % on March 2020 to 0 % on March 2024 . This represents a CAGR of 0.0% over 5 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Par Drugs & Chemicals Ltd

  • Par Drugs and Chemicals Limited was originally incorporated as a Private Limited Company with the name 'Par Drugs and Chemicals Private Limited' at Bhavnagar, Gujarat.
  • On 26 February 1999.
  • Subsequently, the Company was converted into a Public Limited Company and the name was changed to 'Par Drugs and Chemicals Limited' on 5 November 2018. The Company is primarily engaged in manufacturing of Active Pharma Ingredients and fine chemicals (API) for domestic market as well as for exports to international markets.
  • APIs, also known as 'bulk drugs' or 'bulk actives' are the principal ingredient used in making finished dosages in the form of capsules, tablets, liquid, or other forms of dosage, with the addition of other APIs or inactive ingredients. The Company currently own and operate two manufacturing facilities at Bhavnagar and Ankleshwar in the Gujarat.

About Unjha Formulations Ltd

  • Unjha Formulations Ltd was established in Jun.'87 as a partnership firm for manufacturing pharmaceutical formulations in the Mehsana district of Gujarat.
  • It was promoted by Shambhubhai A Patel.
  • The Company is a pioneer in Isabgol (Psyllium) Formulation.
  • The Company is in service to Isabgol (Psyllium) Ayurvedic formulation profession. The company manufactures pharmaceutical formulations like liquids, powder, tablets, capsules, injectibles, etc.
  • It is one of the largest manufacturers of isabgul products in India.

Par Drugs & Chemicals Ltd News Hub

News

Par Drugs & Chemicals announces board meeting date

Par Drugs & Chemicals will hold a meeting of the Board of Directors of the Company on 8 Ma...

Read more

28 Apr 2025 10:10

News

Par Drugs & Chemicals to hold board meeting

Par Drugs & Chemicals will hold a meeting of the Board of Directors of the Company on 14 F...

Read more

06 Feb 2025 21:24

News

Par Drugs & Chemicals to conduct EGM

Par Drugs & Chemicals announced that an Extra Ordinary General Meeting (EGM) of the Compan...

Read more

21 Jan 2025 17:01

News

Par Drugs & Chemicals to conduct EGM

Par Drugs & Chemicals announced that an Extra Ordinary General Meeting (EGM) of the Compan...

Read more

13 Jan 2025 17:11

News

Par Drugs & Chemicals to conduct board meeting

Par Drugs & Chemicals will hold a meeting of the Board of Directors of the Company on 11 J...

Read more

09 Jan 2025 13:38

News

Par Drugs & Chemicals to convene EGM

Par Drugs & Chemicals announced that an Extra Ordinary General Meeting (EGM) of the Compan...

Read more

07 Dec 2024 14:48

Unjha Formulations Ltd News Hub

News

Unjha Formulations to discuss results

Unjha Formulations will hold a meeting of the Board of Directors of the Company on 16 May ...

Read more

23 Apr 2025 10:12

News

Unjha Formulations to hold board meeting

Unjha Formulations will hold a meeting of the Board of Directors of the Company on 17 Marc...

Read more

12 Mar 2025 10:13

News

Unjha Formulations to announce Quarterly Result

Unjha Formulations will hold a meeting of the Board of Directors of the Company on 4 Febru...

Read more

17 Jan 2025 11:04

News

Unjha Formulations to hold board meeting

Unjha Formulations will hold a meeting of the Board of Directors of the Company on 8 Novem...

Read more

17 Oct 2024 12:36

News

Unjha Formulations to hold board meeting

Unjha Formulations will hold a meeting of the Board of Directors of the Company on 1 Augus...

Read more

22 Jul 2024 10:33

News

Unjha Formulations to conduct AGM

Unjha Formulations announced that the 30th Annual General Meeting (AGM) of the company wil...

Read more

09 Jul 2024 17:32

SWOT Analysis Of Unjha Formulations Ltd

Strength

0

S

Weakness

1

W

Opportunity

0

O

Threats

0

T

SWOT Analysis Of Par Drugs & Chemicals Ltd

Strength

1

S

Weakness

1

W

Opportunity

0

O

Threats

1

T

BlinkX Score for Unjha Formulations Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Par Drugs & Chemicals Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Par Drugs & Chemicals Ltd and Unjha Formulations Ltd

Which company has a larger market capitalization, Par Drugs & Chemicals Ltd or Unjha Formulations Ltd?

Market cap of Par Drugs & Chemicals Ltd is 124 Cr while Market cap of Unjha Formulations Ltd is 10 Cr

What are the key factors driving the stock performance of Par Drugs & Chemicals Ltd and Unjha Formulations Ltd?

The stock performance of Par Drugs & Chemicals Ltd and Unjha Formulations Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Par Drugs & Chemicals Ltd and Unjha Formulations Ltd?

As of May 14, 2025, the Par Drugs & Chemicals Ltd stock price is INR ₹101.33. On the other hand, Unjha Formulations Ltd stock price is INR ₹23.03.

How do dividend payouts of Par Drugs & Chemicals Ltd and Unjha Formulations Ltd compare?

To compare the dividend payouts of Par Drugs & Chemicals Ltd and Unjha Formulations Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions